Literature DB >> 24965231

Passage number is a major contributor to genomic structural variations in mouse iPSCs.

Pengfei Liu1, Anna Kaplan, Bo Yuan, Jacob H Hanna, James R Lupski, Orly Reiner.   

Abstract

Emergence of genomic instability is a practical issue in preparing neural stem cells (NSCs) and induced pluripotent stem cells (iPSCs). However, it is still not fully understood what the origins and mechanisms for formation are for the genomic alternations observed. Here, we studied the extent of genomic variation on the scale of individual cells originating from the same animal. We used mouse NSCs grown from embryonic cells and iPSCs generated from embryonic brain cells, B cells or fibroblasts, and performed comparative analysis with cultures of fibroblasts from the same mouse. In the first passage of these cell lines, aneuploidies were only observed for chromosomes 6, 11, 12, 19, and Y, which is overall at a rate lower than previously reported; de novo copy number variations (CNVs) were observed in 4.3% of neural iPSCs, 29% of B cell iPSCs, 10% of fibroblast iPSCs, and 1.3% of neurospheres. In contrast, propagation of these first passage cells to a later passage induced additional aneuploidies and CNVs. Breakpoint sequencing analysis suggested that the majority of the detected CNVs arose by replicative mechanisms. Interestingly, we detected identical de novo CNVs in different single cell colonies that appeared to have arisen independently from each other, which suggests a novel CNV formation mechanism in these cells. Our findings provide insights into mechanisms of CNV formation during reprogramming and suggest that replicative mechanisms for CNV formation accompany mitotic divisions.
© 2014 AlphaMed Press.

Entities:  

Keywords:  Chromosomal aberrations; DNA copy number variations; DNA replication; Induced pluripotent stem cells; Neural stem cells

Mesh:

Year:  2014        PMID: 24965231      PMCID: PMC4165691          DOI: 10.1002/stem.1779

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  29 in total

1.  Chromosomal variation in neurons of the developing and adult mammalian nervous system.

Authors:  S K Rehen; M J McConnell; D Kaushal; M A Kingsbury; A H Yang; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.

Authors:  Junjie Lu; Hu Li; Ming Hu; Takayo Sasaki; Anna Baccei; David M Gilbert; Jun S Liu; James J Collins; Paul H Lerou
Journal:  Cell Rep       Date:  2014-03-27       Impact factor: 9.423

3.  Genetics. Genome mosaicism--one human, multiple genomes.

Authors:  James R Lupski
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

4.  Mosaic copy number variation in human neurons.

Authors:  Michael J McConnell; Michael R Lindberg; Kristen J Brennand; Julia C Piper; Thierry Voet; Chris Cowing-Zitron; Svetlana Shumilina; Roger S Lasken; Joris R Vermeesch; Ira M Hall; Fred H Gage
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728

Review 5.  A genomic view of mosaicism and human disease.

Authors:  Leslie G Biesecker; Nancy B Spinner
Journal:  Nat Rev Genet       Date:  2013-05       Impact factor: 53.242

Review 6.  Origin of murine B cell lineages.

Authors:  A B Kantor; L A Herzenberg
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

7.  A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders.

Authors:  Jennifer A Lee; Claudia M B Carvalho; James R Lupski
Journal:  Cell       Date:  2007-12-28       Impact factor: 41.582

8.  NAHR-mediated copy-number variants in a clinical population: mechanistic insights into both genomic disorders and Mendelizing traits.

Authors:  Piotr Dittwald; Tomasz Gambin; Przemyslaw Szafranski; Jian Li; Stephen Amato; Michael Y Divon; Lisa Ximena Rodríguez Rojas; Lindsay E Elton; Daryl A Scott; Christian P Schaaf; Wilfredo Torres-Martinez; Abby K Stevens; Jill A Rosenfeld; Satish Agadi; David Francis; Sung-Hae L Kang; Amy Breman; Seema R Lalani; Carlos A Bacino; Weimin Bi; Aleksandar Milosavljevic; Arthur L Beaudet; Ankita Patel; Chad A Shaw; James R Lupski; Anna Gambin; Sau Wai Cheung; Pawel Stankiewicz
Journal:  Genome Res       Date:  2013-05-08       Impact factor: 9.043

9.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.

Authors:  Duncan E C Baker; Neil J Harrison; Edna Maltby; Kath Smith; Harry D Moore; Pamela J Shaw; Paul R Heath; Hazel Holden; Peter W Andrews
Journal:  Nat Biotechnol       Date:  2007-02       Impact factor: 54.908

10.  Genome-wide CNV analysis in mouse induced pluripotent stem cells reveals dosage effect of pluripotent factors on genome integrity.

Authors:  Yulin Chen; Lin Guo; Jiekai Chen; Xiangjie Zhao; Weichen Zhou; Cheng Zhang; Jiucun Wang; Li Jin; Duanqing Pei; Feng Zhang
Journal:  BMC Genomics       Date:  2014-01-28       Impact factor: 3.969

View more
  27 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

2.  Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.

Authors:  Luke A Wiley; Kristin R Anfinson; Cathryn M Cranston; Emily E Kaalberg; Malia M Collins; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Curr Protoc Stem Cell Biol       Date:  2017-08-14

3.  iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations.

Authors:  Erika M Kwon; John P Connelly; Nancy F Hansen; Frank X Donovan; Thomas Winkler; Brian W Davis; Halah Alkadi; Settara C Chandrasekharappa; Cynthia E Dunbar; James C Mullikin; Paul Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 4.  Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.

Authors:  Paola Rebuzzini; Maurizio Zuccotti; Carlo Alberto Redi; Silvia Garagna
Journal:  Cell Mol Life Sci       Date:  2016-03-09       Impact factor: 9.261

5.  Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells.

Authors:  Junjie Lu; Hu Li; Anna Baccei; Takayo Sasaki; David M Gilbert; Paul H Lerou
Journal:  Stem Cells Dev       Date:  2016-04-11       Impact factor: 3.272

Review 6.  Advances in reprogramming-based study of neurologic disorders.

Authors:  Anjana Nityanandam; Kristin K Baldwin
Journal:  Stem Cells Dev       Date:  2015-04-06       Impact factor: 3.272

Review 7.  Structural variation mutagenesis of the human genome: Impact on disease and evolution.

Authors:  James R Lupski
Journal:  Environ Mol Mutagen       Date:  2015-04-17       Impact factor: 3.216

Review 8.  Somatic mosaicism: implications for disease and transmission genetics.

Authors:  Ian M Campbell; Chad A Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2015-04-21       Impact factor: 11.639

9.  Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects.

Authors:  Adrian F Daly; Bo Yuan; Frederic Fina; Jean-Hubert Caberg; Giampaolo Trivellin; Liliya Rostomyan; Wouter W de Herder; Luciana A Naves; Daniel Metzger; Thomas Cuny; Wolfgang Rabl; Nalini Shah; Marie-Lise Jaffrain-Rea; Maria Chiara Zatelli; Fabio R Faucz; Emilie Castermans; Isabelle Nanni-Metellus; Maya Lodish; Ammar Muhammad; Leonor Palmeira; Iulia Potorac; Giovanna Mantovani; Sebastian J Neggers; Marc Klein; Anne Barlier; Pengfei Liu; L'Houcine Ouafik; Vincent Bours; James R Lupski; Constantine A Stratakis; Albert Beckers
Journal:  Endocr Relat Cancer       Date:  2016-03-02       Impact factor: 5.678

Review 10.  3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.

Authors:  Xuanyi Ma; Justin Liu; Wei Zhu; Min Tang; Natalie Lawrence; Claire Yu; Maling Gou; Shaochen Chen
Journal:  Adv Drug Deliv Rev       Date:  2018-06-21       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.